Amakem Therapeutics Appoints Dr. James Tsai Of The Yale School Of Medicine To Its Clinical Advisory Board

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DIEPENBEEK, Belgium, March 4, 2014 /PRNewswire/ --

Amakem Therapeutics, a clinical stage ophthalmology company, today announced the appointment of Dr. James Tsai to its Clinical Advisory Board.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC